Pilot study to evaluate the effect of a lifestyle intervention: on quality of physical and mental health in people with schizophrenia treated with either clozapine or another antipsychotic medication who are overweight/obese

Hunter New England Mental Health Local health District0 sites40 target enrollmentMay 14, 2019

Overview

No summary available.

Registry

who.int

Start Date

May 14, 2019

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

Hunter New England Mental Health Local health District

•Age \-18\-65 years
•Taking clozapine for at least 18 weeks and are in maintenance phase or
•have been taking another antipsychotic medication for at least 6 months
•Are overweight or obese – BMI greater than 25
•Have access to transport – either by having their own car, or living in the area and near a bus stop, or have an NDIS support worker who can bring them

•Women who are pregnant
•Acutely unwell (psychotic) or an intellectual disability with severe cognitive impairment which would prevent them from participating in the behavioural program
•Are currently taking medications that may interfere with intervention ( for example metformin, diuretics, any other weight loss medication).
•Persons who are unable to read or write and understand the information statement, consent form, and self\-report measures are ineligible. Informed consent must be obtained to be eligible for the study. As part of the dietary intervention, participants will learn about reading labels so that the right food products can be chosen. Basic level of reading and writing is required for this research.